CAMLINFINE Camlin Fine Q1 FY26 results (Apr–Jun 2025) and concall
Camlin Fine Sciences reported a challenging Q1 FY26 with revenue slightly down to INR423 crores and EBITDA at INR19 crores, impacted by significant one-off costs from annual plant maintenance shutdowns and employee bonuses. Despite these headwinds, the high-growth Blends business continued its strong performance, while the Vanillin segment maintained stable volumes amidst channel stock clearance and evolving tariff dynamics. Management expects a rebound as one-off impacts subside and channel inventories normalize.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 417 | 431 | 432 | 408 |
| EBITDA | 52 | 56 | 62 | 20 |
| Net profit | -116 | -7 | 0 | -11 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
